Billerica, MA and Hayward, CA 3/4/08—Milipore has announced that it will exclusively distribute Guava Technologies’ nonclinical flow cytometers within defined fields in North America, Europe and countries in Asia. Millipore will also provide field service and develop cobranded reagent kits. In addition, the companies will jointly develop new instruments.
In January, BioForce Nanosciences announced the sale of 11 Nano eNablers and the additional placement of 18 systems since the product’s introduction in 2006.
Mobious, which is developing molecular resonance sequencing technology, joined the X Prize competition last year (see IBO 12/31/07). Covaris entered into a supply and distribution agreement with Applied Biosystems for its S2 sample preparation instrument system for use with Applied Biosystems’ SOLiD DNA sequencer. Microfluidics developer RainDance Technologies appointed Christopher McNary president and CEO. He […]
St. Louis, MO 3/7/08—Sigma-Aldrich and Oxford Biomedica have settled their patent litigation against Open Biosystems (see IBO 6/15/06). Under the confidential settlement, Open Biosystems will acquire certain license rights for use of Oxford BioMedica’s LentiVector gene delivery technology in research activities. Other details were not disclosed.
New Orleans, Louisiana, played host to the 59th annual Pittsburgh conference and exhibition (Pittcon), which was held March 1–7 at the Ernest N. Morial Convention Center. Although Pittcon took place against a backdrop of escalating fears of a US recession, one would have never known it. Companies were upbeat about future business prospects and the […]
Abeome granted Millipore an exclusive worldwide license to market and distribute the Human Embryonic Stem Cell Antigen-1 antibody for research use. In December 2007, EMD Chemicals’ Novagen brand licensed Luminex’s xMAP Technology platform in order to develop immunoassays for it. Rules-Based Medicine granted EMD Chemicals exclusive distribution rights to its quantitative protein multiplex assays, and […]
Ingenuity Systems entered into a three-year, $6 million Cooperative Research and Development Agreement with the FDA for the use of biomarkers to monitor drugs.
Luminex launched the FlexmiR Select miRNA Select assay for the creation of customized RNA panels. Genetix released CloneMedia-HEK and CloneMedia-CHOK1. Millipore announced the “Stem Cell Tested” Initiative to ensure that many of its filter products are validated for use on stem cells, starting with the Stericup with Express PLUS membrane. Millipore launched its Tyrosine Kinases […]
Gentelligent launched BasePro 1.0, a downloadable, add-in, Excel-based software for handling DNA, RNA and protein data. Advanced Chemistry Development released ACD/Labs 11, featuring updates for many of its products, including ACD/IntelliXtract for LC/MS componentization. Applied Biosystems released GeneMapper ID-X software for the automation of the routine review of forensic DNA data. Timeless Medical Systems released […]
Norwalk, CT 2/29/08—Applera has announced its Celera subsidiary, one of the company’s two tracking stocks, along with Applied Biosystems, will pursue a possible spin-off from Applera to become a separately traded public firm (see IBO 8/15/07). Celera provides diagnostic products and services. Holders of the Celera tracking stock would receive Celera shares in a one-for-one […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
